The Global Orthobiologics Market valued at $5.4 billion (2021), is set to witness a growth rate of 7% by 2026.Growing number of sports injuries and road accidents, geriatric and obese population ...

The global Orthobiologics Market is projected to be valued at USD 5,762.7 million in 2025, reaching USD 8,287.3 million by 2035, with a compound annual growth rate (CAGR) of 3.7% during the forecast ...

Selecting the right tissue bank is essential for ensuring the safety and effectiveness of allograft implants. Learn how to ...

Mesoblast shares jumped after the biotechnology group reported "continued momentum" with the US Food and Drug Administration ...

Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market ...

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and ...

Korean regenerative medicine company CGBio, affiliated with Daewoong Pharmaceutical, announced Monday the establishment of Sol Cent Bio Co. Ltd., a joint ventur ...

Novadip Biosciences’s bone grafting material NVDX3 has seen all patients achieve bone fracture union in a 12-month Phase Ib/IIa proof-of-concept study. The Belgian company’s NVDX3-CLN01 (NCT05987033) ...